Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Cover image for Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

November 2001

Volume 21, Issue 11

Pages 1317–1454

  1. Editorial

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. You have free access to this content
      A Call for Pharmacists to Improve the Care of Patients with Myocardial Infarction (pages 1317–1319)

      Dr. Kathleen A. Stringer, Dr. Larry Lopez and Dr. Robert L. Talbert

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1317.34429

  2. Original Research Article

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. Susceptibility of Pseudomonas aeruginosa to Cefepime versus Ceftazidime in Patients with Cystic Fibrosis (pages 1320–1324)

      Dr. Christine A. Robinson, Dr., Dr. Robert J. Kuhn, Ms. Lois J. Craigmyle, Dr., Dr. Michael I. Anstead and Dr., Dr. Jamshed F. Kanga

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1320.34420

  3. Brief Reports

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. Prevalence and Risk of Thrombocytopenia with Valproic Acid: Experience at a Psychiatric Teaching Hospital (pages 1325–1330)

      Dr. Erin L. Conley, Dr. Kim C. Coley, Dr. Bruce G. Pollock, Ms. Stacey V. DaPos, Dr. RaeAnn Maxwell and Dr. Robert A. Branch

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1325.34418

    2. Interaction Between N-Acetylcysteine and Activated Charcoal: Implications for the Treatment of Acetaminophen Poisoning (pages 1331–1336)

      Dr. Paul K. Tenenbein, Dr. Daniel S. Sitar and Dr. Milton Tenenbein

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1331.34427

    3. Pharmacoeconomic Evaluation of a Pharmacist-Managed Hypertension Clinic (pages 1337–1344)

      Dr. Mark P. Okamoto and Dr. Randy K. Nakahiro

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1337.34424

    4. Retrospective Evaluation of the Effect of Valproate Therapy on Transaminase Elevations in Patients with Hepatitis C (pages 1345–1351)

      Rex S. Lott, Kristin M. Helmboldt and Karl J. Madaras-Kelly

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1345.34431

  4. Reviews of Therapeutics

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. Lopinavir-Ritonavir: A New Protease Inhibitor (pages 1352–1363)

      Eric M. Mangum and Kathleen K. Graham

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1352.34419

    2. Prussian Blue for Treatment of Radiocesium Poisoning (pages 1364–1367)

      Dennis F. Thompson and Chelsea O. Church

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1364.34426

    3. Triiodothyronine Supplementation in Patients Undergoing Cardiopulmonary Bypass (pages 1368–1374)

      Marc G. Reichert and Kelly C. Verzino

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1368.34425

    4. Levetiracetam: A Novel Antiepileptic Drug (pages 1375–1388)

      Collin A. Hovinga

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1375.34432

  5. Minireview

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. Recombinant Human Activated Protein C, Drotrecogin Alfa (activated): A Novel Therapy for Severe Sepsis (pages 1389–1402)

      Dr. Salmaan Kanji, Dr. John W. Devlin, Dr. Krista A. Piekos and Dr. Eric Racine

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1389.34417

  6. Practice Insights

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. The Value of Pharmacist Involvement in a Point-of-Care Service, Walk-In Lipid Screening Program (pages 1403–1406)

      Dr. Mahtab Jafari, Dr. Mona Masih and Dr. Jane F. Emerson

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1403.34416

    2. Three Michaelis-Menten Pharmacokinetic Dosing Methods Compared with Physician Dosing of Phenytoin in an Outpatient Neurology Practice (pages 1407–1414)

      William J. Spruill, William E. Wade, Henry H. Cobb III and Sara Akbari

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1407.34433

    3. Physician-Prompting Statin Therapy Intervention Improves Outcomes in Patients with Coronary Heart Disease (pages 1415–1421)

      Daniel E. Hilleman, Michael S. Monaghan, Catherine L. Ashby, Joyce E. Mashni, Kathleen Woolley and Cecily M. Amato

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1415.34422

  7. Case Reports

    1. Top of page
    2. Editorial
    3. Original Research Article
    4. Brief Reports
    5. Reviews of Therapeutics
    6. Minireview
    7. Practice Insights
    8. Case Reports
    1. Metformin as a Cause of Late-Onset Chronic Diarrhea (pages 1422–1424)

      Dr. Melissa T. Foss and Dr. Kathi D. Clement

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1422.34430

    2. Treatment Options for a Patient Experiencing Pruritic Rash Associated with Transdermal Testosterone: A Review of the Literature (pages 1425–1435)

      Dr. Nayahmka J. McGriff, Dr. Gyorgy Csako, Dr. Mahmoud Kabbani, Dr. Long Diep, Dr. George P. Chrousos and Dr. Frank Pucino

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1425.34428

    3. Possible Interaction Between Intravenous Azithromycin and Oral Cyclosporine (pages 1436–1443)

      Dr. Robert Lee Page II, Dr. J. Mark Ruscin, Dr. Doug Fish and Dr. Marc LaPointe

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1436.34434

    4. Dramatic Worsening of Type 2 Diabetes Mellitus Due to Olanzapine After 3 Years of Therapy (pages 1444–1447)

      Christopher I. Bechara and Dr. Jennifer D. Goldman-Levine

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1444.34423

    5. Olanzapine-Associated Severe Hyperglycemia, Ketonuria, and Acidosis: Case Report and Review of Literature (pages 1448–1454)

      Dr. Heather L. Seaburg, Dr. Beth M. McLendon and Dr. P. Murali Doraiswamy

      Version of Record online: 17 JAN 2012 | DOI: 10.1592/phco.21.17.1448.34421

SEARCH

SEARCH BY CITATION